Clinical Trial Results:
Multicentric, open-label, single-arm phase II study with oral lapatinib in combination with oral capecitabine plus intrathecally administered liposomal cytarabine (DepoCyte®) for the treatment of meningeal metastasis or meningeal metastasis plus brain metastases in HER2-positive breast-cancer patients
Summary
|
|
EudraCT number |
2009-012706-39 |
Trial protocol |
DE |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
12 Mar 2021
|
First version publication date |
12 Mar 2021
|
Other versions |
|
Summary report(s) |
Study report |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.